Test Directory
| Test Code | |||
| TP53S | |||
| Test Name | |||
| TP53 Somatic Mutation, Prognostic | |||
| CPT Codes | |||
| 81352 | |||
| Expected Turnaround Time | |||
| 3 - 4 days | |||
| Clinical Utility | |||
|
Somatic mutation of the p53 tumor suppressor gene is the most common genetic alteration seen in human cancers, with >50% of adult human tumors bearing inactivating mutations or insertions, deletions in the P53 gene. Wild type p53 prevents genetic instability and participates in the apoptotic response to radiotherapy and chemotherapy. Mutations in P53 gene usually correlate with poor outcome and early recurrence in cancer. This test provides important prognostic and prodictive information for patients with B-CLL, breast cancer, cervical cancer, melanoma or other cancers. |
|||
| Specimen and Container Info | |||
|
Specimen Type: Whole Blood
Collection Container: Lavender Top (EDTA) Desired Specimen Volume: 6 mL |
|||
| Collection Instructions | |||
|
|||
| Processing and Submission Instructions | |||
|
|||
| Transport Instructions | |||
|
Transport to the laboratory refrigerated. |
|||
| Stability Requirements | |||
|
|||
| Methodology | |||
| Next Gen Sequencing (NGS) | |||
| Reference Intervals | |||
|
See patient report. |
|||
| Reference Lab | |||
| Quest Diagnostics Nichols Institute | |||
| Testing Schedule | |||
| Routine, 2 times per week | |||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.